221 related articles for article (PubMed ID: 36803948)
1. eRNA profiling uncovers the enhancer landscape of oesophageal adenocarcinoma and reveals new deregulated pathways.
Ahmed I; Yang SH; Ogden S; Zhang W; Li Y; ; Sharrocks AD
Elife; 2023 Feb; 12():. PubMed ID: 36803948
[TBL] [Abstract][Full Text] [Related]
2. Repurposing of KLF5 activates a cell cycle signature during the progression from a precursor state to oesophageal adenocarcinoma.
Rogerson C; Ogden S; Britton E; ; Ang Y; Sharrocks AD
Elife; 2020 Sep; 9():. PubMed ID: 32880368
[TBL] [Abstract][Full Text] [Related]
3. Expression of neuroepithelial transforming gene 1 is enhanced in oesophageal cancer and mediates an invasive tumour cell phenotype.
Lahiff C; Cotter E; Casey R; Doran P; Pidgeon G; Reynolds J; Macmathuna P; Murray D
J Exp Clin Cancer Res; 2013 Aug; 32(1):55. PubMed ID: 23945136
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.
Gharahkhani P; Fitzgerald RC; Vaughan TL; Palles C; Gockel I; Tomlinson I; Buas MF; May A; Gerges C; Anders M; Becker J; Kreuser N; Noder T; Venerito M; Veits L; Schmidt T; Manner H; Schmidt C; Hess T; Böhmer AC; Izbicki JR; Hölscher AH; Lang H; Lorenz D; Schumacher B; Hackelsberger A; Mayershofer R; Pech O; Vashist Y; Ott K; Vieth M; Weismüller J; Nöthen MM; ; ; ; Attwood S; Barr H; Chegwidden L; de Caestecker J; Harrison R; Love SB; MacDonald D; Moayyedi P; Prenen H; Watson RGP; Iyer PG; Anderson LA; Bernstein L; Chow WH; Hardie LJ; Lagergren J; Liu G; Risch HA; Wu AH; Ye W; Bird NC; Shaheen NJ; Gammon MD; Corley DA; Caldas C; Moebus S; Knapp M; Peters WHM; Neuhaus H; Rösch T; Ell C; MacGregor S; Pharoah P; Whiteman DC; Jankowski J; Schumacher J
Lancet Oncol; 2016 Oct; 17(10):1363-1373. PubMed ID: 27527254
[TBL] [Abstract][Full Text] [Related]
5. Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
Jammula S; Katz-Summercorn AC; Li X; Linossi C; Smyth E; Killcoyne S; Biasci D; Subash VV; Abbas S; Blasko A; Devonshire G; Grantham A; Wronowski F; O'Donovan M; Grehan N; Eldridge MD; Tavaré S; ; Fitzgerald RC
Gastroenterology; 2020 May; 158(6):1682-1697.e1. PubMed ID: 32032585
[TBL] [Abstract][Full Text] [Related]
6. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
[TBL] [Abstract][Full Text] [Related]
7. MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma.
Fisher OM; Levert-Mignon AJ; Lord SJ; Lee-Ng KK; Botelho NK; Falkenback D; Thomas ML; Bobryshev YV; Whiteman DC; Brown DA; Breit SN; Lord RV
Br J Cancer; 2015 Apr; 112(8):1384-91. PubMed ID: 25867265
[TBL] [Abstract][Full Text] [Related]
8. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma.
Fitzgerald RC
Gut; 2006 Dec; 55(12):1810-20. PubMed ID: 17124160
[No Abstract] [Full Text] [Related]
10. The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival.
Duggan SP; Behan FM; Kirca M; Zaheer A; McGarrigle SA; Reynolds JV; Vaz GM; Senge MO; Kelleher D
Sci Rep; 2016 Sep; 6():32638. PubMed ID: 27586588
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas.
Soldes OS; Kuick RD; Thompson IA; Hughes SJ; Orringer MB; Iannettoni MD; Hanash SM; Beer DG
Br J Cancer; 1999 Feb; 79(3-4):595-603. PubMed ID: 10027336
[TBL] [Abstract][Full Text] [Related]
12. Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development.
Watts JA; Zhang C; Klein-Szanto AJ; Kormish JD; Fu J; Zhang MQ; Zaret KS
PLoS Genet; 2011 Sep; 7(9):e1002277. PubMed ID: 21935353
[TBL] [Abstract][Full Text] [Related]
13. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma.
Jiménez P; Piazuelo E; Cebrian C; Ortego J; Strunk M; García-Gonzalez MA; Santander S; Alcedo J; Lanas A
Aliment Pharmacol Ther; 2010 Feb; 31(3):440-51. PubMed ID: 19843025
[TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
16. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
[TBL] [Abstract][Full Text] [Related]
17. Hnf4α is a key gene that can generate columnar metaplasia in oesophageal epithelium.
Colleypriest BJ; Burke ZD; Griffiths LP; Chen Y; Yu WY; Jover R; Bock M; Biddlestone L; Quinlan JM; Ward SG; Mark Farrant J; Slack JMW; Tosh D
Differentiation; 2017; 93():39-49. PubMed ID: 27875772
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
Hao Y; Triadafilopoulos G; Sahbaie P; Young HS; Omary MB; Lowe AW
Gastroenterology; 2006 Sep; 131(3):925-33. PubMed ID: 16952561
[TBL] [Abstract][Full Text] [Related]
19. Differential SPARC mRNA expression in Barrett's oesophagus.
Brabender J; Lord RV; Metzger R; Park J; Salonga D; Danenberg KD; Danenberg PV; Hölscher AH; Schneider PM
Br J Cancer; 2003 Oct; 89(8):1508-12. PubMed ID: 14562024
[TBL] [Abstract][Full Text] [Related]
20. Evolution and progression of Barrett's oesophagus to oesophageal cancer.
Killcoyne S; Fitzgerald RC
Nat Rev Cancer; 2021 Nov; 21(11):731-741. PubMed ID: 34545238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
